Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentSarah F Ackley, Michael Flanders, Ruijia Chen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumSarah F Ackley, Michael Flanders, Ruijia Chen, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|August 14, 2016
Adjustable surgical treatment of adult exotropia: postoperative target angles and surgical successEmmanuelle Chalifoux, Maan Alkharashi, Rosanne Superstein, et al.Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Evaluation of Amyloid Removal as a Surrogate for Cognitive Decline: Pilot Analysis in Individual-Level Data from the A4 Study of SolanezumabSarah F Ackley, Michael Flanders, Audrey Murchland, et al.Journal of Virology|October 28, 2011
HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcomeSrinika Ranasinghe, Michael Flanders, Sam Cutler, et al.American Journal of Epidemiology|August 21, 2025
Trends in the Distribution of P Values in Epidemiology Journals: A Statistical, P-Curve, and Simulation StudySarah F Ackley, Ryan M Andrews, Christopher Seaman, et al.Science Translational Medicine|March 2, 2012
HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcomeDamien Z Soghoian, Heiko Jessen, Michael Flanders, et al.Journal of Virology|November 5, 2010
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell functionMathieu F Chevalier, Boris Jülg, Augustine Pyo, et al.Blood|March 16, 2011
Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functionsHendrik Streeck, Douglas S Kwon, Augustine Pyo, et al.Blood Cancer Discovery|September 13, 2021
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional AnalysisVictoria E Wang, Bradley W Blaser, Ravi K Patel, et al.Pageof 2